JPWO2023003815A5 - - Google Patents
Info
- Publication number
- JPWO2023003815A5 JPWO2023003815A5 JP2024502611A JP2024502611A JPWO2023003815A5 JP WO2023003815 A5 JPWO2023003815 A5 JP WO2023003815A5 JP 2024502611 A JP2024502611 A JP 2024502611A JP 2024502611 A JP2024502611 A JP 2024502611A JP WO2023003815 A5 JPWO2023003815 A5 JP WO2023003815A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- pharmaceutical composition
- actrii
- seq
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163223265P | 2021-07-19 | 2021-07-19 | |
| US63/223,265 | 2021-07-19 | ||
| PCT/US2022/037479 WO2023003815A1 (en) | 2021-07-19 | 2022-07-18 | Actrii proteins and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024526820A JP2024526820A (ja) | 2024-07-19 |
| JP2024526820A5 JP2024526820A5 (https=) | 2025-07-17 |
| JPWO2023003815A5 true JPWO2023003815A5 (https=) | 2025-07-17 |
Family
ID=84979535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502611A Pending JP2024526820A (ja) | 2021-07-19 | 2022-07-18 | Ａｃｔｒｉｉタンパク質およびその用途 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20240327494A1 (https=) |
| EP (1) | EP4373577A4 (https=) |
| JP (1) | JP2024526820A (https=) |
| KR (1) | KR20240049857A (https=) |
| CN (1) | CN117957014A (https=) |
| AU (1) | AU2022316103A1 (https=) |
| CA (1) | CA3225613A1 (https=) |
| CL (1) | CL2024000151A1 (https=) |
| CO (1) | CO2024001551A2 (https=) |
| CR (1) | CR20240061A (https=) |
| DO (1) | DOP2024000016A (https=) |
| EC (1) | ECSP24012819A (https=) |
| GE (1) | GEAP202416461A (https=) |
| IL (1) | IL310141A (https=) |
| JO (1) | JOP20240010A1 (https=) |
| MX (1) | MX2024000829A (https=) |
| PE (1) | PE20240777A1 (https=) |
| WO (1) | WO2023003815A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021189010A1 (en) | 2020-03-20 | 2021-09-23 | Keros Therapeutics, Inc. | Methods of using activin receptor type iib variants |
| IL296394A (en) | 2020-03-20 | 2022-11-01 | Keros Therapeutics Inc | Type ii activin receptor chimeras and methods of using them |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180055822A1 (en) * | 2015-03-13 | 2018-03-01 | Repoceuticals Aps | Melatonin for Preventing and Treating Radiation Cystitis |
| CA3005975A1 (en) * | 2015-11-23 | 2017-06-01 | Acceleron Pharma Inc. | Methods for treating eye disorders |
| HRP20210694T1 (hr) * | 2016-07-15 | 2021-09-17 | Acceleron Pharma, Inc. | Pripravci koji sadrže actriia polipeptide za uporabu za liječenje plućne hipertenzije |
-
2022
- 2022-07-18 GE GEAP202416461A patent/GEAP202416461A/en unknown
- 2022-07-18 AU AU2022316103A patent/AU2022316103A1/en active Pending
- 2022-07-18 KR KR1020247005282A patent/KR20240049857A/ko active Pending
- 2022-07-18 CR CR20240061A patent/CR20240061A/es unknown
- 2022-07-18 IL IL310141A patent/IL310141A/en unknown
- 2022-07-18 MX MX2024000829A patent/MX2024000829A/es unknown
- 2022-07-18 CA CA3225613A patent/CA3225613A1/en active Pending
- 2022-07-18 CN CN202280060109.7A patent/CN117957014A/zh active Pending
- 2022-07-18 US US18/580,425 patent/US20240327494A1/en active Pending
- 2022-07-18 JP JP2024502611A patent/JP2024526820A/ja active Pending
- 2022-07-18 EP EP22846466.5A patent/EP4373577A4/en active Pending
- 2022-07-18 PE PE2024000111A patent/PE20240777A1/es unknown
- 2022-07-18 WO PCT/US2022/037479 patent/WO2023003815A1/en not_active Ceased
-
2024
- 2024-01-17 CL CL2024000151A patent/CL2024000151A1/es unknown
- 2024-01-18 JO JOJO/P/2024/0010A patent/JOP20240010A1/ar unknown
- 2024-01-18 DO DO2024000016A patent/DOP2024000016A/es unknown
- 2024-02-14 CO CONC2024/0001551A patent/CO2024001551A2/es unknown
- 2024-02-19 EC ECSENADI202412819A patent/ECSP24012819A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022105138A5 (https=) | ||
| US8617555B2 (en) | Pharmaceutical compositions comprising activated-potentiated antibodies to human insulin receptor and endothelial nitric oxide (NO) synthase | |
| JP2017538395A5 (https=) | ||
| JP2025032102A5 (https=) | ||
| RU2005127429A (ru) | Активная иммунизация для создания антител к растворимому а-бета | |
| JP2022502367A5 (https=) | ||
| CN103154028A (zh) | 复合药物组合物以及对神经退行性疾病相关的疾病或病症进行治疗的方法 | |
| CN104010656B (zh) | 使用免疫球蛋白和c1-抑制剂的联合疗法 | |
| JP2019519528A5 (https=) | ||
| JP2023040169A5 (https=) | ||
| JP2021526534A5 (https=) | ||
| CN110799522B (zh) | 用于治疗、改善或预防脑出血的肽及其用途 | |
| JP2016536369A5 (https=) | ||
| JP2023052614A5 (https=) | ||
| JP2018501201A5 (https=) | ||
| JP2022501368A5 (https=) | ||
| RU2019122135A (ru) | Антитело против адреномедуллина (adm) или фрагмент анти-adm антитела, или анти-adm не-ig каркас для применения при вмешательстве и терапии гиперемии у пациента | |
| Floege et al. | Present and future therapy options in IgA-nephropathy | |
| JP2017524675A5 (https=) | ||
| FI114011B (fi) | Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi | |
| JPWO2023003815A5 (https=) | ||
| IL310164A (en) | Multi-chain chimeric polypeptides and use thereof in the treatment of liver diseases | |
| JPWO2022056484A5 (https=) | ||
| JP6094485B2 (ja) | ビリルビン排泄促進剤 | |
| JP7217287B2 (ja) | アミロイド症の処置および予防 |